Insider · CIK 0001790029

Bozic Carmen

Reports to the SEC for 1 company · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001790029

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-26	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−596 sh	$482.50	−$288K	15,337
2026-06-18	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−1,020 sh	$462.17	−$471K	15,933
2026-06-15	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−4,062 sh	$450.00	−$1.83M	16,953
2026-06-05	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−1,745 sh	$450.00	−$785K	21,015
2026-05-29	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−1,974 sh	$450.00	−$888K	22,760
2026-05-15	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−1,354 sh	$453.45	−$614K	24,734
2026-05-12	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−6,988 sh	$450.00	−$3.14M	26,088
2026-03-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−2,329 sh	$450.95	−$1.05M	33,076
2026-03-13	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−2,329 sh	$481.79	−$1.12M	35,405
2026-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−2,329 sh	$480.31	−$1.12M	37,734
2026-02-24	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP and CMO	FTax Payment	−1,453 sh	$485.11	−$705K	40,063
2026-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP and CMO	AAward	+5,375 sh	—	—	43,428
2026-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP and CMO	FTax Payment	−1,912 sh	$483.75	−$925K	41,516
2026-02-13	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP and CMO	FTax Payment	−3,804 sh	$487.76	−$1.86M	38,053
2026-02-10	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP and CMO	FTax Payment	−2,145 sh	$468.41	−$1M	41,857
2026-01-22	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP and CMO	AAward	+7,866 sh	—	—	40,535
2026-01-22	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP and CMO	AAward	+3,467 sh	—	—	44,002
2025-02-26	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP and CMO	FTax Payment	−4,962 sh	$479.61	−$2.38M	32,669
2025-02-24	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP and CMO	FTax Payment	−3,310 sh	$483.28	−$1.6M	37,631
2025-02-14	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP and CMO	FTax Payment	−1,912 sh	$463.46	−$886K	40,941
2025-02-12	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP and CMO	AAward	+5,546 sh	—	—	42,853
2025-02-10	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP and CMO	FTax Payment	−2,142 sh	$467.98	−$1M	37,307
2025-02-04	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP and CMO	AAward	+10.3K sh	—	—	33,521
2025-02-04	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP and CMO	AAward	+5,928 sh	—	—	39,449
2024-08-07	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−2,280 sh	$476.75	−$1.09M	23,259
2024-07-24	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−2,280 sh	$488.46	−$1.11M	25,539
2024-07-10	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−2,280 sh	$487.34	−$1.11M	27,819
2024-06-26	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−2,280 sh	$471.72	−$1.08M	30,099
2024-06-12	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−2,280 sh	$478.00	−$1.09M	32,379
2024-05-29	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−2,280 sh	$445.56	−$1.02M	34,659
2024-02-23	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP and CMO	FTax Payment	−3,309 sh	$431.79	−$1.43M	36,939
2024-02-20	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP and CMO	FTax Payment	−2,812 sh	$420.58	−$1.18M	40,248
2024-02-16	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP and CMO	FTax Payment	−3,750 sh	$424.01	−$1.59M	43,060
2024-02-09	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP and CMO	FTax Payment	−2,100 sh	$422.74	−$888K	46,810
2024-02-07	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP and CMO	AAward	+5,928 sh	—	—	48,910
2024-02-06	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP and CMO	AAward	+7,866 sh	—	—	42,982
2024-02-06	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP and CMO	AAward	+5,814 sh	—	—	35,116
2023-11-14	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−5,650 sh	$380.82	−$2.15M	29,302
2023-10-31	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−5,651 sh	$355.92	−$2.01M	34,952
2023-10-17	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−5,651 sh	$373.25	−$2.11M	40,603
2023-10-03	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−5,651 sh	$345.28	−$1.95M	46,254
2023-09-19	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−5,651 sh	$351.00	−$1.98M	51,905
2023-09-05	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP and CMO	SSale	−5,651 sh	$352.66	−$1.99M	57,556
2023-02-24	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP and CMO	FTax Payment	−3,308 sh	$289.12	−$956K	63,207
2023-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP and CMO	FTax Payment	−3,750 sh	$292.85	−$1.1M	66,515
2023-02-13	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP and CMO	FTax Payment	−4,992 sh	$298.26	−$1.49M	70,265
2023-02-10	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP and CMO	FTax Payment	−2,707 sh	$294.33	−$797K	75,257
2023-02-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP and CMO	AAward	+10.3K sh	—	—	59,836
2023-02-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP and CMO	AAward	+10.3K sh	—	—	70,098
2023-02-01	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP and CMO	AAward	+7,866 sh	—	—	77,964

Recent filings

Accepted (ET)
Jun 304
Bozic Carmen0000875320-26-000239
SEC(opens sec.gov)
Jun 234
Bozic Carmen0000875320-26-000237
SEC(opens sec.gov)
Jun 174
Bozic Carmen0000875320-26-000235
SEC(opens sec.gov)
Jun 94
Bozic Carmen0000875320-26-000233
SEC(opens sec.gov)
Jun 24
Bozic Carmen0000875320-26-000228
SEC(opens sec.gov)
May 194
Bozic Carmen0000875320-26-000225
SEC(opens sec.gov)
May 144
Bozic Carmen0000875320-26-000222
SEC(opens sec.gov)
Mar 314
Bozic Carmen0000875320-26-000149
SEC(opens sec.gov)
Mar 174
Bozic Carmen0000875320-26-000140
SEC(opens sec.gov)
Mar 34
Bozic Carmen0000875320-26-000127
SEC(opens sec.gov)
Feb 264
Bozic Carmen0000875320-26-000110
SEC(opens sec.gov)
Feb 194
Bozic Carmen0000875320-26-000086
SEC(opens sec.gov)
Feb 184
Bozic Carmen0000875320-26-000066
SEC(opens sec.gov)
Feb 124
Bozic Carmen0000875320-26-000042
SEC(opens sec.gov)
Jan 264
Bozic Carmen0000875320-26-000016
SEC(opens sec.gov)
Feb 284
Bozic Carmen0000875320-25-000129
SEC(opens sec.gov)
Feb 264
Bozic Carmen0000875320-25-000109
SEC(opens sec.gov)
Feb 194
Bozic Carmen0000875320-25-000087
SEC(opens sec.gov)

Companies

VERTEX PHARMACEUTICALS INC / MAEVP and CMOVRTX

Address

C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE

BOSTON, MA, 02210